ResMed, Inspire Medical Drop After Lilly’s Zepbound Study
"ResMed and Inspire Medical stocks plummet after Eli Lilly's Zepbound trial success; Citi downgrades RMD, sees market shift. Read more ...
- Latest
- Trending
"ResMed and Inspire Medical stocks plummet after Eli Lilly's Zepbound trial success; Citi downgrades RMD, sees market shift. Read more ...
Should the FAFSA account for household wealth? Explore how including wealth data could more fairly distribute student financial aid. Deadline: ...
Bitcoin funds lost $630M amid $1.2B asset outflows in two weeks; investor sentiment sways due to interest rate concerns, yet ...
Dogecoin's trading volume surged 186%, hitting $1.37B. Despite a 25.48% monthly drop, high interest suggests potential price recovery.
"Dogecoin falters, while crypto whales shift from Binance Coin (BNB) to ETFSwap (ETFS), boosting its presale and redefining ETF trading."
RBC identifies LVMH as a profitable investment despite recent underperformance, forecasting a +27% potential upside amid strong competitive advantages.
Eurofins Scientific stock plunges by 20% amid Muddy Waters' short-seller allegations of complex corporate structure and questionable practices.
"Dogecoin, Polygon, and Maker see significant liquidations; new presale altcoin Rollblock (RBLK) poised to reignite the bull run."
"Eurozone equities face challenges from political uncertainty, despite stronger fundamentals. Cautious short-term outlook advised by analysts."
Bitcoin whales adopt risk-off mode, per CryptoQuant CEO; declining interexchange-flow-pulse marks cautious market stance as ETH's MVRV rises.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.